Co-Authors
This is a "connection" page, showing publications co-authored by Ali Rabaan and Kuldeep Dhama.
Connection Strength
7.189
-
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19. Diagnostics (Basel). 2021 Jun 15; 11(6).
Score: 0.951
-
Immunopathogenesis and immunobiology of SARS-CoV-2. Infez Med. 2021 Jun 01; 29(2):167-180.
Score: 0.948
-
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens. 2021 May 07; 10(5).
Score: 0.944
-
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel). 2021 Apr 29; 9(5).
Score: 0.943
-
COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021 Oct; 49(5):833-853.
Score: 0.240
-
COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021 Oct 03; 17(10):3495-3499.
Score: 0.238
-
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. Ann Clin Microbiol Antimicrob. 2021 Jan 18; 20(1):8.
Score: 0.231
-
Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'. Hum Vaccin Immunother. 2020 12 01; 16(12):2888-2890.
Score: 0.229
-
Recent advances in vaccine and immunotherapy for COVID-19. Hum Vaccin Immunother. 2020 12 01; 16(12):3011-3022.
Score: 0.228
-
Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19. Curr Trop Med Rep. 2020 Sep 24; 1-7.
Score: 0.226
-
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020 Sep 02; 19(1):40.
Score: 0.225
-
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med Infect Dis. 2020 Sep - Oct; 37:101830.
Score: 0.224
-
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum Vaccin Immunother. 2020 12 01; 16(12):2891-2904.
Score: 0.223
-
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis. 2020 Sep - Oct; 37:101755.
Score: 0.221
-
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview Infez Med. 2020 Ahead Of Print Jun 1; 28(2):174-184.
Score: 0.215
-
COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns. Hum Vaccin Immunother. 2021 Nov 02; 17(11):4108-4111.
Score: 0.060
-
Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies. Hum Vaccin Immunother. 2021 Oct 03; 17(10):3491-3494.
Score: 0.060
-
AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021 Mar-Apr; 40:101989.
Score: 0.058
-
Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021; 10:40.
Score: 0.058
-
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis. F1000Res. 2021; 10:34.
Score: 0.058
-
SARS-CoV-2 reinfection and implications for vaccine development. Hum Vaccin Immunother. 2020 12 01; 16(12):3061-3073.
Score: 0.057
-
Impact of COVID-19 on tourism in Nepal. J Travel Med. 2020 09 26; 27(6).
Score: 0.057
-
Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res. 2020; 9:1107.
Score: 0.056
-
Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps. Ann Clin Microbiol Antimicrob. 2020 07 18; 19(1):30.
Score: 0.056
-
Mapping the Changes on Incidence, Case Fatality Rates and Recovery Proportion of COVID-19 in Afghanistan Using Geographical Information Systems. Arch Med Res. 2020 08; 51(6):600-602.
Score: 0.055
-
MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies. Infez Med. 2020 Jun 01; 28(suppl 1):71-83.
Score: 0.055
-
A vaccine is not too far for COVID-19. J Infect Dev Ctries. 2020 May 31; 14(5):450-453.
Score: 0.055
-
Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools. Arch Med Res. 2020 07; 51(5):450-452.
Score: 0.055
-
Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers. Travel Med Infect Dis. 2020 Mar - Apr; 34:101630.
Score: 0.054
-
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr; 34:101623.
Score: 0.054
-
Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020 Ahead of print Jun 1; 28(2):139-142.
Score: 0.054